CCL5 and nonpapillary renal cell carcinoma: In addition, our research was not able to include in-depth experiments on the mechanism of the pro-tumorigenic role of CCL5 in ccRCC and CCL5+ TAMs in regulating an aberrant TME status, which might reflect the potential replicability issues in clustering patients with differential CCL5+ TAMs infiltration status.